Recent Quotes

My Watchlist

Indicators

Overview

News

Currencies

International

Treasuries

Syndax Pharmaceuticals, Inc. - Common Stock (NQ:SNDX)

11.16 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 5, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	11.16
Bid (Size)	10.51 (1)
Ask (Size)	12.00 (2)
Prev. Close	11.16
Today's Range	11.16 - 11.16
52wk Range	8.580 - 25.07
Shares Outstanding	69,484,053
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

June 05, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Syndax Announces Participation in June Investor Conferences

May 29, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Performance

YTD	-20.7%	-20.7%
1 Month	-16.8%	-16.8%
3 Month	-28.8%	-28.8%
6 Month	-33.3%	-33.3%
1 Year	-44.4%	-44.4%

More News

Let's uncover which stocks are experiencing notable gaps during today's session.

May 20, 2025

Via Chartmill

Earnings Scheduled For May 5, 2025

May 05, 2025

Via Benzinga

Agilysys, Amer Sports, X Financial And Other Big Stocks Moving Higher On Tuesday

May 20, 2025

Via Benzinga

Syndax Announces Data Presentations at EHA 2025 Showcasing Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr)

May 14, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer

May 12, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Syndax Announces Participation in May Investor Conferences

May 08, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Syndax Announces Publication of Pivotal Revumenib Data in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia in the Journal Blood

May 07, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session

May 06, 2025

Via Benzinga

Syndax Reports First Quarter 2025 Financial Results and Provides Business Update

May 05, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

May 02, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

NXP Semiconductors, Brinker International, Ultra Clean, Sanmina And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

April 29, 2025

Via Benzinga

Why Leggett & Platt Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

April 29, 2025

Via Benzinga

Syndax to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 5, 2025

April 28, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

April 02, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Syndax's Revuforj Earns Strong Physician Support, JP Morgan Predicts Sales Growth

March 21, 2025

Via Benzinga

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

March 05, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Syndax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

March 03, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Earnings Scheduled For March 3, 2025

March 03, 2025

Via Benzinga

Syndax Announces Participation in March Investor Conferences

February 25, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025

February 24, 2025

From Syndax Pharmaceuticals, Inc.

Via GlobeNewswire

Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks

January 17, 2025

Via Investor's Business Daily

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.

January 09, 2025

Via Investor's Business Daily

Roku To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday

November 18, 2024

Via Benzinga

Frequently Asked Questions

Is Syndax Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Syndax Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Syndax Pharmaceuticals, Inc. - Common Stock trade on?

Syndax Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Syndax Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Syndax Pharmaceuticals, Inc. - Common Stock is SNDX on the Nasdaq Stock Market

What is the current price of Syndax Pharmaceuticals, Inc. - Common Stock?

The current price of Syndax Pharmaceuticals, Inc. - Common Stock is 11.16

When was Syndax Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Syndax Pharmaceuticals, Inc. - Common Stock was at 06/05/25 04:00 PM ET

What is the market capitalization of Syndax Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Syndax Pharmaceuticals, Inc. - Common Stock is 775.44M

How many shares of Syndax Pharmaceuticals, Inc. - Common Stock are outstanding?

Syndax Pharmaceuticals, Inc. - Common Stock has 775M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.